Leukocyte adhesion to endothelium plays a critical initiating role in inflammation. Berberine, an antiinflammatory natural compound, is known to attenuate lipopolysaccharide (LPS)-induced lung injury and improve survival of endotoxemic animals with mechanism not fully clarified. This study investigated the effects of berberine on the LPS-induced leukocyte-endothelial cell adhesion both in vivo and in vitro. We first established an animal model to observe the in vivo LPS-induced adhesion of leukocytes to the endothelium of venules in the lung tissue dose-dependently. Pretreatment of LPS-stimulated rats with berberine for 1 h reduced the leukocyte-endothelium adhesion and vascular cell adhesion molecule-l (VCAM-l) expression in lung. Pretreatment of LPS-stimulated vascular endothelial cells with berberine also dose-dependently decreased the number of adhered THP-l cells and VCAM-l expression at both RNA and protein levels. Berberine was further confirmed to inhibit the nuclear translocation and DNA binding activity of LPS-activated nuclear factor-kappa B (NF-kappa B) . These data demonstrated an additional molecular mechanism for the profound anti-inflammatory effect of berberine.
Berberine, a natural compound isolated from Chinese medicinal herbs such as Cortexphellodendri and Rhizoma coptidis, possesses significant antiinflammatory effects and has been used clinically to treat chronic inflammation-associated diseases such as diabetes (1, 2) , hypertension (3, 4) and dyslipidemia (5) (6) (7) . In vivo animal studies have shown that berberine can attenuate acute lung injury and improve survival in endotoxemic mice which is mediated, at least in part, by the modulation of cytokine production (8) . Lungs are among the most frequently affected organs in severe sepsis leading to acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) (9, 10) . The initial site affected during the development ofALIIARDS is the layer of endothelial cells lining the micro-vessels in the lung (11) . The response of lung microvascular endothelial cells to lipopolysaccharide (LPS) is central to the pathogenesis of lung injury (12) . Sepsis-induced acute lung injury is characterized by activation and injury of vascular endothelial cells, increased leukocyte-endothelial cell adhesion, migration and infiltration. Endothelial activation, defined as up-regulation of cell adhesion molecules such as VCAM-I, constitutes a critical initial step in the recruitment of leukocytes to foci of inflammation (13) (14) (15) . Shortly after the stimulation, the mRNA level of these adhesion molecules is known to be upregulated by the activation and nuclear translocation of transcription factor NF-kappa B (16) .
The present study aims to assess the in vivo and in vitro anti-inflammatory effects of berberine on the leukocyte-endothelial cell adhesion and VCAM-I expression in LPS-stimulated rat and human vascular endothelial cells, respectively. The effect of berberine on the nuclear translocation and DNA binding activity of NF-kappa B in human vascular endothelial cells was also examined.
MATERIALS AND METHODS

Reagent
Berberine chloride (Empirical Formula: C2oH18CIN04; Molecular Weight: 371.81), was used in this study and was purchased from Sigma-Aldrich Co. (St. Louis, Missouri 63103, USA)
Animal experiments
All animal experiments were approved by the Animal Experiment Committee of the Chang Gung University. Male Sprague-Daley rats weighing 200-250 g were purchased from BioLasco Taiwan Co. and maintained on a normal diet for a week before experiments. The rats were randomly divided into 4 groups (six rats in each group): control group, LPS group, berberine 5mg/kg + LPS group, and berberine 10mglkg + LPS group. Vehicle (50% ethanol in distilled water, O.lml/lO g body weight for control group and LPS group) or berberine (5 mg or 10mg/kg in 0.1 ml vehicle/lO g body weight) was injected intraperitoneally 1 h before the intraperitoneal injection of LPS (5mg/kg, in 0.2 ml PBS/10 g body weight). Control rats received intraperitoneal injection of vehicle and then 0.2 ml PBS/l 0 g body weight. The rats were sacrificed 9 h after LPS injection and the lungs were prepared for histological examination by HE stain and immunostaining ofVCAM-1. The number of leukocytes adhered to endothelium of venules in the lung tissue was counted. The length of endothelium was measured by Image Pro® plus (Media Cybernetics, Inc.) and the result was presented as the number of adhered leukocytes I length of endothelium in millimeters.
Cell cultures
Endothelial cells were isolated from human umbilical cord vein (HUVECs) by a modified collagenase method, as described previously (17) (18) (19) . Cells were grown to confluence in medium 199 supplemented with 20% EGM-2 and 16% FBS. Confluent cultures of endothelial cells at passage 3-5 were used for experiments. The human monocytic leukemia cell line, THP-l, was obtained from ATCC and grown in suspension culture in RPMI 1640 medium supplemented with 10% FBS and antibiotics. Cells were maintained at 37°C in a humidified atmosphere with 5% CO 2 I 95% air.
Cell adhesion assay
Confluent culture of endothelial cells with or without the berberine pretreatment for 1 h was stimulated by 51lg! ml LPS for 4 h and used for cell adhesion assay. Equal numbers ofTHP-l cells (2 x 10 5 ) were added to the culture of endothelial cells after replacing berberine-containing medium with fresh growth medium and incubated at 37°C in a humidified 95% airl 5% CO 2 incubator for 30 min and non-adhered cells were removed by gentle washing with medium 199 twice, and the number of adhered THP-1 cells was counted under a microscope.
MTTassay
Cells with or without berberine treatment for 24 h were washed once with PBS, followed by adding 1 ml M199 containing 0.05mg!ml 3-[4, 5-dimethylthiazol-2-yl]-2, 5-diphenyltetrazolium bromide (MTT). After incubation at 37°C for 1 h, the media were removed and formazan crystals in the cells were solubilized in 1 ml DMSO for OD reading at 570 nm using a spectrophotometer.
RNA isolation and RT/real-time PCR
Total cellular RNA was isolated by lysis in a guanidinium isothiocyanate buffer followed by a one-step phenol-chloroform-isoamyl alcohol extraction (20) . One ug of total RNA was reverse-transcribed into cDNA by incubating with 200 u of reverse transcriptase in 20 III of reaction buffer containing 0.25 ug of random primers and 0.8 mM dNTPs at 42°C for 1 h and the transcribed first strand cDNA was used for PCR reaction as the template. Aliquots (20 ng) ofcDNA were used for each reaction in a 20 III reaction mix (10 IlM primer, 2X Real Q-PCRMaster Mix, 6 III DEPC HP) with the SYBR Green method and a MxPro-Mx3000P QPCR machine (Stratagene, La Jolla, CA). Each sample was run in triplicate, and GAPDH was used as the normalizer housekeeping gene. Data between two groups were analyzed using MxPro software.
Western blot analysis
Cell extracts were prepared in lysis buffer containing Tris-HC1,pH7.5, 150mMNaCl, 1mMEDTA,2mMDTT, 2 mM PMSF and 1% Triton X-I 00 by sonication method. The same amount of proteins as determined by Bradford assay (Bio-Rad Laboratories, CA, USA) was separated by 12% SDS-PAGE and transferred onto a PVDF membrane. Membrane was incubated at room temperature in blocking solution containing 1% BSA and 1% goat serum in PBS for 30 min, followed by 2 h incubation in blocking solution containing primary antibody (anti-VCAM-1, 1:100, Santa Cruz Biotechnology, Inc. CA, USA; anti-tubulin, 1:800, Lab Vision, CA, USA). After washing, the membrane was then incubated in PBS containing HRP-conjugated IgG for 1 h. After washing, positive signals were developed with enhanced chemiluminescence (Amershan Pharmacia Biotech, England).
Immunocytochemistry
Cells grown on cover slides were fixed in 4% formaldehyde (pH 7.5) for 15 min at room temperature and immersed in blocking solution containing 1% BSA and 1% goat serum in PBS for 30 min followed by the incubation with 100x dilution of monoclonal antibody against NFkappa B p65 (Santa Cruz Biotechnology, Inc.) in blocking solution for 60 min. DAKO labeled streptavidin-biotin 2 system-HRP was used to detect the signal and color development was performed by incubation with DAB substrate-chromogen for 5 min. After counterstaining, the cell nuclei with hematoxylin, coverslides were mounted and observed under microscope.
Gel mobility shift assay
Nuclear extract was prepared from human endothelial cells according to the procedure described previously (21) . Oligonucleotides used as probe or competitor were chemically synthesized according to the sequence of NFkappa B binding site in the promoter of human VCAM-l gene (sense strand: 5'-CTTGAAGGGATTTCCCTC-3'; anti-sense strand: 5' -GAGGGAAATCCCTTCAAG-3 ') and labeled with [y_32P]ATP by using T4 polynucleotide kinase. Nuclear extracts (5-10 ug) were incubated with 2 ug of poly(dI-dC).poly(dI-dC) in 20~l of binding buffer containing 10 mM Tris-HC1, pH 7.5, 1 mM EDTA, 1 mM dithiothreitol, and 5% glycerol for 10 min at room temperature. 32P-labeled DNA probe (10,000 cpm) was then added to the reaction mixture, and incubation was continued for another 20 min. The DNA-protein complexes were analyzed on a 6% polyacrylamide gel at 170 V using 0.25 xTBE as electrophoresis buffer. Gels were dried and processed for autoradiography.
Statistical analysis
Results are expressed as mean ± standard error of mean (SEM). Statistical differences were determined by independent and paired Student's t-test in unpaired and paired samples. Whenever a control group was compared with more than one treated group, one-way ANOVA was used instead. P values of less than 0.05 were considered statistically significant.
RESULTS
The in vivo leukocyte-endothelium adhesion was studied by a single intraperitoneal injection of LPS (0,2, 5, and lOmglKg) to Male Sprague-Daley rats and the lung tissues were prepared for histochemical examination. Dose-dependent increase of leukocytes adhering to the endothelium of postcapillary venules in rat lungs was observed 9 h after LPS stimulation (Fig. 1, A and B, *p < 0.0001 when control vs 2, 5 or IOmg/kg LPS, one-way ANOVA). Rats with or without berberine pretreatment which received LPS injection (5mg/kg, i.p.) were sacrificed 9 h after, and lung tissues were processed for histochemical analysis. LPS induced significant increase ofadhered leukocytes to endothelium of lung venules (Fig. 2 , A and B, "P < 0.0001 when control vs LPS, paired student t test). Pretreatment of rats with berberine (5mg/kg or IOmg/kg, i.p.) 1 h before LPS stimulation dose-dependently attenuated LPS-induced leukocyte adhesion to endothelium of lung venules (Fig. 2 , A and B, *P< 0.0001 when LPS vs 5, 10 mg/kg berberine, one-way ANOVA). Pretreatment with berberine up to lOmg/kg abolished 90% of the LPS-induced increase of leukocyte adhesion to endothelium of lungvenules.
As shown in . Fig. 3 , the lack of detectable VCAM-l protein expression in the negative control ruled out the potential background problem during immunohistochemical analysis. The VCAM-1 protein expression was weakly detected in the endothelium of venules in rat lung from the control group. LPS injection (5mg/kg, i.p.) induced a significant increase of VCAM-l expression in parallel with the number of adhered leukocytes. Intraperitoneal injection of berberine (lOmg/kg) before LPS stimulation attenuated the VCAM-l expression of endothelium as well as reducing the number of adhered leukocytes.
Leukocyte-endothelial monolayer adhesion assay under static condition is a well-documented in vitro model to study the interaction between leukocytes and endothelial cells (22) . We used this model to examine the effect of berberine on the adhesion of human monocytic THP-l cells to LPS-stimulated HUVECs. As shown in Fig. 4, A (23) . Since the culture condition of HUVECs in the present study was different from previous reports, we therefore performed additional MTT assay and the result in Fig. 4C demonstrates that berberine at the concentrations we used in this study for 24 h had no significant effect on the viability of HUVECs. This result ruled out the possibility that the decrease of cell adhesion might be caused by the cytotoxic effect of berberine on HUVECs. VCAM-lexpression is known to be induced in HUVECs by the stimulation with LPS, which is (A) 
LPS
-. Fig. 5 . Berberine inhibited the VCAM-J expression at both the protein and mRNA levels. A) Confluent HUVECs were pretreated with or without 50f.1g/ml berberine for J hand LPS was then added for different time periods as indicated. Protein expression was analyzed by Western blot analysis and statistical data were calculated by densitometric analysis. B) Confluent HUVECs were pretreated with or without berberine at different concentrations as indicated for J hand LPS was added for 4 h. Proteins were preparedfor the analysis ofVCAM-J expression by Western blot method and statistical data were calculated by densitometric analysis. C) Same as in (B), total RNA was isolatedfor RT/real-time PCR analysis using GAPDH as an internal control. Acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) are characterized by leukocyte infiltration, cytokine release, microvascular and alveolar epithelial injury, pulmonary edema, and severe hypoxemia. It is still a difficult clinical problem with a high mortality rate although the antimicrobial therapy and supportive care have greatly improved (25) . Therefore, additional therapeutic targets to reduce the mortality are still worthy of investigation. Sepsis is one of the most important causes of ALI. Clinically, the lung is the most frequently identified organ to fail as acute respiratory distress syndrome in sepsis (10) . Although the mechanism underlying sepsis-induced ALI is not fully understood, endotoxin or LPS has been demonstrated to play an important role in the pathogenesis. Injured endothelium is a key step involved in the pathogenesis of sepsis and multiple organ failure (26) . Leukocyte infiltration normally plays a critical role in host defensive mechanism, however, accompanying tissue injury may occur when excessive accumulation of leukocytes locally produces large amounts ofoxidative stress, cytokines (A) and matrix metalloproteinases that inevitably damage the surrounding tissues (27, 28) .
Berberine ofLPS
. Berberine dose-dependently inhibited the adhesion of THP-I cells to LPS-stimulated HUVECs in vitro. A) Microphotographs (LOt) ») show the adhesion of THP-I cells to LPS-stimulated HUVECs under three conditions as indicated. B) Dose-dependent inhibition on the number ofTHP-l cells adhered to LPS-stimulated
In the present study, we successfully observed the in vivo leukocyte-endothelial cell adhesion in LPS-challenged rat lung. The number of adhered leukocytes to the endothelium induced by LPS was demonstrated to be dose-dependent. This animal model is therefore useful for the study of leukocyteendothelium interaction, an initial step ofinflammation and lung injury. Using this animal model, we found that berberine, as a well-known anti-inflammatory drug, inhibited the in vivo leukocyte-endothelial cell adhesion and VCAM-l expression in LPS-challenged rat lung. Previous studies have shown that berberine can reduce pulmonary edema, leukocyte infiltration, histopathological alterations of lung and improve survival in endotoxemic mice induced by LPS (8) . In addition to the decrease of inflammatory cytokine production, upregulation of IL-lO release and inhibition of cytosolic phospholipase A2 expression, our results further provided an explanation for the beneficial effect of berberine on reducing leukocyte adhesion and VCAM-l expression in vascular endothelial cells both in vivo and in vitro.
The present study also demonstrates the inhibitory effect of berberine on nuclear translocation and DNA-binding activity of NF-kappa B that may suggest a profound anti-inflammatory consequence. Berberine, as a major component of HMC05, has been demonstrated to dose-dependently inhibit tumor necrosis factor-a (TNF-a)-induced expressions of monocyte chemoattractant protein-l (MCP-l), intercellular cell adhesion molecule-l (ICAM-l) and VCAM-l in human vascular endothelial cells. These findings are also correlated well with the inhibition of TNF-a-induced NF-kappa B activation by berberine (23) . A recent clinical study demonstrated that berberine can significantly reduce the incidence of radiation-induced lung injury, improve pulmonary function and decrease the levels of sICAM-l and TGF-betal (29) . Although the exact mechanisms remain unclarified, the inhibitory effect ofberberine on NF-kappa B activity is likely to playa potential role. Berberine, one of the most studied compounds among the naturally occurring protoberberine alkaloids, has a long history of medicinal use in many countries (30) . The studies of pharmacologic modulation of berberine may help us to understand more about the anti-inflammatory properties of its clinical treatment in many different diseases as long as the pathogenesis is related with the inflammatory events.
